Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) narrowed second quarter losses significantly to 8 cents per share from losses of 35 cents per share in the year ago period as revenue rose. The stock price gained 21 cents to close at $1.77.
Arrowhead Pharmaceuticals narrows losses
May 04, 2017 at 16:49 PM EDT
